Peregrine Pharmaceuticals traded at $16.71 this Wednesday July 6th, increasing $0.35 or 2.14 percent since the previous trading session. Looking back, over the last four weeks, Peregrine Pharmaceuticals gained 16.04 percent. Over the last 12 months, its price fell by 36.92 percent. Looking ahead, we forecast Peregrine Pharmaceuticals to be priced at 14.91 by the end of this quarter and at 13.73 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agenus 2.43 0.02 0.83% -54.92%
Amgen 245.25 -1.48 -0.60% 0.83%
AstraZeneca 10,978.00 178.00 1.65% 26.80%
BioCryst Pharmaceuticals 11.23 0.09 0.81% -29.33%
Bristol-Myers Squibb 76.22 0.26 0.34% 13.52%
ChemoCentryx 25.33 -1.52 -5.66% 75.05%
Celldex Therapeutics 23.99 -0.76 -3.07% -17.13%
GlaxoSmithKline 1,790.20 3.60 0.20% 24.58%
Immunogen 5.15 0.25 5.10% -16.94%
Karyopharm Therapeutics 5.22 -0.09 -1.69% -48.16%
Eli Lilly 330.15 2.97 0.91% 40.00%
MacroGenics 3.42 0.11 3.32% -87.76%
MannKind 4.12 0.07 1.73% -17.43%
Merck & Co 93.13 0.49 0.53% 18.55%
Minerva Neurosciences 3.21 -0.04 -1.23% 38.96%
Lumos Pharma Inc. 7.47 -0.12 -1.58% -25.89%
Novartis 81.22 0.31 0.38% -4.41%
Novavax 63.54 -0.75 -1.17% -65.80%
Peregrine Pharmaceuticals 16.71 0.35 2.14% -36.92%
Repligen 168.45 0.77 0.46% -18.41%
Roche Holding 323.35 4.35 1.36% -9.16%
Xencor 32.44 1.99 6.54% -4.14%
Intrexon 1.46 -0.16 -9.88% -75.95%

Indexes Price Day Year
USND 11362 39.61 0.35% -22.52%
US2000 1728 -13.78 -0.79% -23.32%

Peregrine Pharmaceuticals
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The Company provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The Company also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.